Iyuda Therapeutics, Inc. — Form D/A
Iyuda Therapeutics, Inc. of Owings Mills, MD, a company, filed a Form D amendment with the SEC on 2025-06-06. The offering totals $1.3M, of which $1.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-06-06
- Form: D/A
- Accession: 0000905148-25-002036
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.3M
- Amount sold: $1.3M
- Investors: 3
- Date of first sale: 2024-10-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-527351
Issuer
- Name: Iyuda Therapeutics, Inc.
- CIK: 0001993594
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 3217 Hunting Tweed Dr., Owings Mills, MD, 21117
- Phone: 202-913-8697
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Ephraim Fuchs | Director | Owings Mills, MD |
| Robert Tennant | Executive Officer | Owings Mills, MD |
| Robert Tennant | Related Person | Owings Mills, MD |
| Ephraim Fuchs | Related Person | Owings Mills, MD |
Other filings by this issuer (5)
More